ARTHRITIS & RHEUMATOLOGY, vol.73, no.9, pp.1673-1682, 2021 (SCI-Expanded)
Article / Article
ARTHRITIS & RHEUMATOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE
Eskisehir Osmangazi University Affiliated:
Objective. Cyclophosphamide (CYC) is used in clinical practice off-label for the induction of remission in childhood polyarteritis nodosa (PAN). Mycophenolate mofetil (MMF) might offer a less toxic alternative. This study was undertaken to explore the relative effectiveness of CYC and MMF treatment in a randomized controlled trial (RCT).